Barclays Lowers XPeng Price Target to $16

1 min read Reproduced verbatim
Rating
Underweight
Unchanged
Target
$16
from $17 (−6%)
Outcome
Reached
on April 23, 2026
Barclays and XPeng logos

What the analyst said

Barclays analyst Jiong Shao lowered the price target on XPeng (NYSE: XPEV) to $16.00 (from $17.00) while maintaining an Underweight rating.

“Summary: Q1 delivery guide is a bit below our expectations but the company is launching several new models in 2026.

The issue we see is that ’26 is shaping up as a pretty difficult year for NEVs in China as the government is cutting back on tax incentives and a number of EV makers are launching new models.

While management is hopeful and optimistic about the sales of their new models, visibility into success of these new models is limited, needless to say.

The only bright spot we see for Chinese EV makers is the overseas market and we agree with XPEV management that the company should focus on growing its overseas sales by over 100% in ’26 (to over 20% of total vehicle sales).

Separately, the company has been aggressively investing in robotaxi and humanoid robots and has some aspirational year-end targets for both new initiatives.

We are a bit concerned about both the company’s resources and management stretching itself a bit too thin when investing in multiple new areas.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

XPEV trades at $10.24. The 7 analysts who set a target in the last 3 months range from $10 to $22, with a median of $16. This $16 target is in line with the median.

Since the note XPEV has moved −42% (from $17.55). 12-month window: day 229 of 365, closes on March 23, 2027.

Track record

This call✓ Target reached on April 23, 2026, 31 days after the note.

Firm track recordBarclays: 83% of its 40 targets at least a year old were reached within 12 months (#7 of 26 firms). Accuracy ranking →

Earnings reactionOne of 7 notes after XPeng’s Mar 20 results: 1 raised · 2 cut · 1 kept. See every call →

Barclays on XPeng

Barclays price targets on XPeng

3 calls from February 19, 2026 to August 25, 2026. The target went from $17 to $14 (−18%). The rating stayed Sell.

Barclays targetXPEV share price
  1. August 25, 2026Target cut from $16 (−13%)Sell$14
  2. March 23, 2026 This noteTarget cut from $17 (−6%)Sell$16
  3. February 19, 2026Earliest call shownSell$17
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.